Day: December 21, 2022

ORIC and Pfizer have entered into a clinical development collaboration for a Phase 2 study of ORIC-533 in combination with elranatamab in multiple myeloma Jeff Settleman, Ph.D., Chief Scientific Officer, Pfizer Oncology, to join ORIC Scientific Advisory Board Including $25 million equity investment from Pfizer, ORIC cash runway extended into 1H 2025 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Dec. 21, 2022 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical-stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that it has entered into a clinical development collaboration for a potential Phase 2 study of ORIC-533 in multiple myeloma with Pfizer and agreed to sell 5,376,344 of its common shares at a price of $4.65 per share to Pfizer for proceeds...

STAMFORD, Conn., Dec. 21, 2022 (GLOBE NEWSWIRE) — Patriot National Bancorp, Inc. (“Patriot,” “Bancorp” or the “Company”) (NASDAQ: PNBK), the parent company of Patriot Bank, National Association (the “Bank”), today announced the issuance and sale (the “Offering”) of $12 million in aggregate principal amount of 8.50% Fixed-Rate Senior Notes due 2026 (the “Notes”). The Company used the proceeds from the Offering to repay in full its 7.50% Senior Notes, due on December 31, 2022. The Notes bear interest at a fixed annual rate of 8.50%, payable semi-annually in arrears on January 15 and July 15 of each year, beginning July 15, 2023. The Notes’ maturity date is January 15, 2026. The Company is entitled to redeem the Notes, in whole or in part, on or after January 15, 2025, and to redeem the Notes at any time in whole upon certain other...

Production Up, Costs per Ounce Down TORONTO, Dec. 21, 2022 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is pleased to report our production for October and November along with our forecast for 2022 and guidance for 2023. The bottom line, production is increasing and costs per ounce are falling. “As we end 2022, we would like to give our shareholders an update on our recent production results and costs which illustrate the turnaround we are executing as well as our guidance for 2023. We had a difficult start to 2022 but it is clear that we are trending up and in the right direction as we move into the new year.” said Rob McEwen, Chairman and Chief Owner. Table 1 below provides production and cost results for 2021, October and November 2022, full year 2022 forecast, our production guidance range for full year 2022,...

Bal Harbour, FL, Dec. 21, 2022 (GLOBE NEWSWIRE) — Sports Ventures Acquisition Corp. (NASDAQ: AKIC) (the “Company”) announced today that, due to its inability to consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association (the “Charter”), the Company intends to dissolve and liquidate in accordance with the provisions of its Charter and will redeem all of the outstanding shares of Class A common stock that were included in the units issued in its initial public offering (the “Public Shares”), at a per-share redemption price of approximately $10.12. In order to provide for the disbursement of funds from the trust account, the Company has instructed the trustee of the trust account to take all necessary actions to liquidate the securities held in the...

CARLSBAD, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) — AppTech Payments Corp. (AppTech) (NASDAQ: APCX), an innovative Fintech company powering seamless, omni-channel commerce between businesses and consumers, holds Fireside Chat between AppTech CEO, Luke D’Angelo, and CNBC and Fox Business Network Market Analyst Kenny Polcari. Polcari sits down with D’Angelo to discuss future growth and outlines the most recent Company events. Viewers can watch the interview here: https://www.youtube.com/watch?v=7wtwhYGv4Bs AppTech was also recently viewed on Fox business as one of the best long-term companies to have in your five-year stock plan, seen here: http://video.foxbusiness.com/v/6317511890112/. About Kenny Polcari Polcari is currently the Managing Partner of Kace Capital Advisors, Chief Market Strategist at SlateStone Wealth, sits on the...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS TORONTO, Dec. 21, 2022 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial-stage, international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based, cannabinoid-based products, today announced the promotion of Phillip Cardella to Chief Financial Officer (CFO) effective immediately. Mr. Cardella has served as the Company’s interim CFO since May 2022. Previously, Mr. Cardella held the position of Senior Vice President of Finance at the Company, and prior to joining the Company practiced accounting with MNP LLP. The...

PRINCETON, N.J., Dec. 21, 2022 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the 41st Annual J.P. Morgan Healthcare conference on January 11, 2023 at 7:30pm ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at http://investor.integralife.com/events-and-presentations. About Integra LifeSciencesIntegra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®,...

Posts Strong Adjusted EBITDA Margin of 20.9% for Fiscal Year 2022 CINCINNATI, Dec. 21, 2022 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fourth quarter and fiscal year 2022 financial results and operational highlights. These results pertain to the three months and year ended September 30, 2022 and are reported in U.S. Dollars. Quipt will host its Earnings Conference Call on Thursday, December 22, 2022 at 10:00 a.m. (ET). The dial-in number is 1 (800) 319-4610 or 1 (604) 638-5340. The live audio webcast can be found on the investor section of the Company’s website through the following link: www.quipthomemedical.com. Financial Highlights:Revenue for fiscal year 2022 was $139.9 million...

NEW YORK, New York, Dec. 21, 2022 (GLOBE NEWSWIRE) — Shelter Acquisition Corporation I (the “Company”) (Nasdaq: SHQA, SHQAU, SHQAW) has announced that, at a special meeting of stockholders held on December 21, 2022, the stockholders approved an amendment to the Company’s amended and restated certificate of incorporation to change the date by which the Company must consummate a business combination from January 2, 2023 to June 30, 2023 or such earlier date as determined by the board of directors of the Company (the “board”) to be in the best interests of the Company (such date, the “Termination Date”). Because the Company does not believe it will be able to complete an initial business combination by the Termination Date, on December 21, 2022, the board unanimously determined it is in the best interest of the Company to liquidate...

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR HONG KONG, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Aberdeen, 21st December 2022 Reference is made to the stock exchange release from Awilco Drilling Plc (“Awilco Drilling” or the “Company”) (Euronext Growth: AWDR) published on 21st December 2021 regarding a contemplated private placement of new Sponsored Norwegian Depository Receipts in the Company up to NOK 78 million (equivalent to USD 8 million) in gross proceeds (the “Private Placement”) The Company is pleased to announce that the Private Placement has...